Company Profile of INIST ST Co., LTD

Founded in 2000 in the name of Dongwoo SynTech Co., Ltd. INIST ST has headed developing raw material medicine and its synthesis technology. Based on change and innovation, and love for life, INIST ST has researched and developed excellent-quality generic raw materials and new salt IMDs (incrementally modified drug) starting from cerebrovascular medicine and has supplied them domestically and overseas.

Based on the long-accumulated firm trust and technology, the company developed multiple first generic raw materials, which have led to the development of innovative new drugs such as a contrast medium for heart disease, and calcium channel blocker anticancer drug. The company’s advanced technology moves it beyond the high market barriers of developed countries into the global market such as over KRW 50 billion export to the medically advanced country of Japan.

INIST ST, in order to respond to the rapidly changing global market and more complicated diseases, continues its research with the spirit of change and innovation, and love for life.